Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretics Withdrawal in HFrEF (REDICAE)
NCT05964738Phase 2Completed
- Sponsor
- Maimónides Institute of Biomedical Research of Córdoba
- Start
- Dec 2022
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in heart failure with reduced ejection fraction (HFrEF) (2 arms), sponsored by Maimónides Institute of Biomedical Research of Córdoba. Primary endpoint: Dyspnea assessed by a visual analogue scale at 180 days. Started Dec 2022; status: completed.
02
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT05964738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05964738.